These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27084892)

  • 1. Prevalence of Non-Cytochrome P450-Mediated Metabolism in Food and Drug Administration-Approved Oral and Intravenous Drugs: 2006-2015.
    Cerny MA
    Drug Metab Dispos; 2016 Aug; 44(8):1246-52. PubMed ID: 27084892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 and Non-Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics.
    Foti RS; Dalvie DK
    Drug Metab Dispos; 2016 Aug; 44(8):1229-45. PubMed ID: 27298339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: A Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016.
    Saravanakumar A; Sadighi A; Ryu R; Akhlaghi F
    Clin Pharmacokinet; 2019 Oct; 58(10):1281-1294. PubMed ID: 30972694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of non-human primates in drug development: Comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes.
    Uno Y; Uehara S; Yamazaki H
    Biochem Pharmacol; 2016 Dec; 121():1-7. PubMed ID: 27318253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity.
    Crouch RD; Morrison RD; Byers FW; Lindsley CW; Emmitte KA; Daniels JS
    Drug Metab Dispos; 2016 Aug; 44(8):1296-303. PubMed ID: 26936972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High daily dose and being a substrate of cytochrome P450 enzymes are two important predictors of drug-induced liver injury.
    Yu K; Geng X; Chen M; Zhang J; Wang B; Ilic K; Tong W
    Drug Metab Dispos; 2014 Apr; 42(4):744-50. PubMed ID: 24464804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Metabolism in the Liver.
    Almazroo OA; Miah MK; Venkataramanan R
    Clin Liver Dis; 2017 Feb; 21(1):1-20. PubMed ID: 27842765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of metabolites to P450 inhibition-based drug-drug interactions: scholarship from the drug metabolism leadership group of the innovation and quality consortium metabolite group.
    Yu H; Balani SK; Chen W; Cui D; He L; Humphreys WG; Mao J; Lai WG; Lee AJ; Lim HK; MacLauchlin C; Prakash C; Surapaneni S; Tse S; Upthagrove A; Walsky RL; Wen B; Zeng Z
    Drug Metab Dispos; 2015 Apr; 43(4):620-30. PubMed ID: 25655830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytochrome P450 enzymes and their role in drug interactions].
    Papp-Jámbor C; Jaschinski U; Forst H
    Anaesthesist; 2002 Jan; 51(1):2-15. PubMed ID: 11963295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity.
    Guengerich FP
    Toxicol Lett; 1994 Feb; 70(2):133-8. PubMed ID: 8296317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
    Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
    Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-cytochrome P450-mediated bioactivation and its toxicological relevance.
    Gan J; Ma S; Zhang D
    Drug Metab Rev; 2016 Nov; 48(4):473-501. PubMed ID: 27533622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug metabolites as cytochrome p450 inhibitors: a retrospective analysis and proposed algorithm for evaluation of the pharmacokinetic interaction potential of metabolites in drug discovery and development.
    Callegari E; Kalgutkar AS; Leung L; Obach RS; Plowchalk DR; Tse S
    Drug Metab Dispos; 2013 Dec; 41(12):2047-55. PubMed ID: 23792812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of non-P450 enzymes in drug oxidation.
    Beedham C
    Pharm World Sci; 1997 Dec; 19(6):255-63. PubMed ID: 9443166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of human cytochrome P450 enzymes involved in the hepatic and intestinal biotransformation of 20(S)-protopanaxadiol.
    Chiu NT; Tomlinson Guns ES; Adomat H; Jia W; Deb S
    Biopharm Drug Dispos; 2014 Mar; 35(2):104-18. PubMed ID: 24151189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?
    Doherty MM; Charman WN
    Clin Pharmacokinet; 2002; 41(4):235-53. PubMed ID: 11978143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactions and enzymes in the metabolism of drugs and other xenobiotics.
    Testa B; Pedretti A; Vistoli G
    Drug Discov Today; 2012 Jun; 17(11-12):549-60. PubMed ID: 22305937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.